Trial reportFrontiers in immunology2026
E-based physical exercise in patients with multiple sclerosis and comorbidity (COMPACT): feasibility study and protocol for a randomized controlled trial.
Trial report in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06298201 (Investigating of Effects of e-Based Physical Exercise in Patients With Multiple Sclerosis and Comorbidity), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Investigating of Effects of e-Based Physical Exercise in Patients With Multiple Sclerosis and Comorbidity
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Comorbidity is prevalent among people with multiple sclerosis (pwMS) and may contribute to disease progression. Physical exercise (PE) reduces symptoms in pwMS and also benefits comorbidities. Digital (e)-based PE has been proposed as a tool to support the integration of PE. Aims: To describe a protocol for a randomized controlled trial (RCT) based on a structured approach and the results from a controlled feasibility study of an e-based PE intervention in pwMS with and without comorbidities. Method: In a RCT following a feasibility study (n=50), patients will be randomly assigned in a 1:1 ratio to receive either usual care (n=150) or usual care plus an e-based PE program at home (n=150). The exercise program consists of resistance training with resistance bands targeting the lower extremities. The sessions will enable participants to engage in group exercises from their homes, supervised online by physiotherapists, two 60-minute sessions per week for 6 months (24 weeks and 48 sessions). The primary endpoint is change of walking capacity using the 6-minutes' walk test. Secondary endpoints include "no evidence of disease activity" (NEDA)-3 scale, measures of quality of life and fatigue as well as levels of neurofilament light chain in blood and cerebrospinal fluid.Results of the feasibility study: Fifty individuals were eligible and randomized to an intervention group (n = 23) or to a usual care control group (n = 27). A total of 24 sessions were conducted for three months in groups of 6, supervised by the physiotherapist. In the intervention group, two pwMS did not begin the PE program due to occupational constraints with a resulting recruitment rate of 91.3% (21/23). Of the remaining 21 individuals, 16 (76.2%) completed the follow-up assessments with a mean attendance of 15.2 (range 6-22) sessions per participant, corresponding to a 63% adherence rate. No intervention-related adverse events were reported. Conclusion: This protocol describes a prospective RCT study and the supporting feasibility data of an e-based PE performed at home. The effects of e-based PE performed at home will be evaluated, offering a significant contribution to the field of digital healthcare solutions and MS. Clinical Trial Registration: https://clinicaltrials.gov/, identifier NCT06298201.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.